158 related articles for article (PubMed ID: 15610563)
1. In vitro activity of antiamoebic drugs against clinical isolates of Entamoeba histolytica and Entamoeba dispar.
Bansal D; Sehgal R; Chawla Y; Mahajan RC; Malla N
Ann Clin Microbiol Antimicrob; 2004 Dec; 3():27. PubMed ID: 15610563
[TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance in amoebiasis patients.
Bansal D; Sehgal R; Chawla Y; Malla N; Mahajan RC
Indian J Med Res; 2006 Aug; 124(2):189-94. PubMed ID: 17015933
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiamoebic activity of metronidazole thiosemicarbazone analogues.
Abid M; Agarwal SM; Azam A
Eur J Med Chem; 2008 Sep; 43(9):2035-9. PubMed ID: 18242785
[TBL] [Abstract][Full Text] [Related]
4. Public health and clinical importance of amoebiasis in Malaysia: a review.
Tengku SA; Norhayati M
Trop Biomed; 2011 Aug; 28(2):194-222. PubMed ID: 22041740
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of amoebiasis in a model research community and its confirmation using stool antigen elisa for Entamoeba histolytica.
Akhtar T; Khan AG; Ahmed I; Nazli R; Haider J
Pak J Pharm Sci; 2016 Sep; 29(5):1587-1590. PubMed ID: 27731816
[TBL] [Abstract][Full Text] [Related]
6. Drug resistance in amoebiasis.
Bansal D; Malla N; Mahajan RC
Indian J Med Res; 2006 Feb; 123(2):115-8. PubMed ID: 16575108
[TBL] [Abstract][Full Text] [Related]
7. [Differentiation of Entamoeba histolytica from Entamoeba dispar using Gal/GalNAc-lectin and polymerase chain reaction].
López OY; López MC; Corredor V; Echeverri MC; Pinilla AE
Rev Med Chil; 2012 Apr; 140(4):476-83. PubMed ID: 22854693
[TBL] [Abstract][Full Text] [Related]
8. Creep in nitroimidazole inhibitory concentration among the Entamoeba histolytica isolates causing amoebic liver abscess and screening of andrographolide as a repurposing drug.
Singh A; Banerjee T; Shukla SK; Upadhyay S; Verma A
Sci Rep; 2023 Jul; 13(1):12192. PubMed ID: 37500681
[TBL] [Abstract][Full Text] [Related]
9. Pathogenicity of Entamoeba dispar under xenic and monoxenic cultivation compared to a virulent E. histolytica.
Costa AO; Gomes MA; Rocha OA; Silva EF
Rev Inst Med Trop Sao Paulo; 2006; 48(5):245-50. PubMed ID: 17086310
[TBL] [Abstract][Full Text] [Related]
10. Experimental amoebic liver abscess in hamsters caused by trophozoites of a Brazilian strain of Entamoeba dispar.
Guzmán-Silva MA; Santos HL; Peralta RS; Peralta JM; de Macedo HW
Exp Parasitol; 2013 May; 134(1):39-47. PubMed ID: 23380037
[TBL] [Abstract][Full Text] [Related]
11. Metronidazole hydrazone conjugates: Design, synthesis, antiamoebic and molecular docking studies.
Ansari MF; Siddiqui SM; Agarwal SM; Vikramdeo KS; Mondal N; Azam A
Bioorg Med Chem Lett; 2015 Sep; 25(17):3545-9. PubMed ID: 26174554
[TBL] [Abstract][Full Text] [Related]
12. Differences in protein profiles of the isolates of Entamoeba histolytica and E. dispar by surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF MS) ProteinChip assays.
Makioka A; Kumagai M; Kobayashi S; Takeuchi T
Parasitol Res; 2007 Dec; 102(1):103-10. PubMed ID: 17846790
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiamoebic activity of 3,7-dimethyl-pyrazolo[3,4-e][1,2,4] triazin-4-yl thiosemicarbazide derivatives.
Singh S; Husain K; Athar F; Azam A
Eur J Pharm Sci; 2005 Jun; 25(2-3):255-62. PubMed ID: 15911221
[TBL] [Abstract][Full Text] [Related]
14. Molecular epidemiology of amoebiasis in Malaysia: highlighting the different risk factors of Entamoeba histolytica and Entamoeba dispar infections among Orang Asli communities.
Anuar TS; Al-Mekhlafi HM; Abdul Ghani MK; Abu Bakar E; Azreen SN; Salleh FM; Ghazali N; Bernadus M; Moktar N
Int J Parasitol; 2012 Dec; 42(13-14):1165-75. PubMed ID: 23123168
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic methods for differentiation of Entamoeba histolytica and Entamoeba dispar in carriers: performance and clinical implications in a non-endemic setting.
Visser LG; Verweij JJ; Van Esbroeck M; Edeling WM; Clerinx J; Polderman AM
Int J Med Microbiol; 2006 Oct; 296(6):397-403. PubMed ID: 16753339
[TBL] [Abstract][Full Text] [Related]
16. Entamoeba dispar: ultrastructure, surface properties and cytopathic effect.
Espinosa-Cantellano M; Gonzáles-Robles A; Chávez B; Castañ ón G; Argüello C; Lázaro-Haller A; Martínez-Palomo A
J Eukaryot Microbiol; 1998; 45(3):265-72. PubMed ID: 9669863
[TBL] [Abstract][Full Text] [Related]
17. [Epidemiologic and molecular study of Entamoeba histolytica and Entamoeba dispar strains in pacients with diarrhea in Cumana, Sucre state, Venezuela].
Mora L; García A; De Donato M; Urdaneta H
Invest Clin; 2008 Jun; 49(2):225-37. PubMed ID: 18717268
[TBL] [Abstract][Full Text] [Related]
18. Detection of Entamoeba histolytica antigen in stool samples in Mersin, Turkey.
Delialioglu N; Aslan G; Ozturk C; Ozturhan H; Sen S; Emekdas G
J Parasitol; 2008 Apr; 94(2):530-2. PubMed ID: 18564756
[TBL] [Abstract][Full Text] [Related]
19. Entamoeba histolytica or Entamoeba dispar among children in Gaza, Gaza Strip?
Al-Hindi A; Shubair ME; Marshall I; Ashford RW; Sharif FA; Abed AA; Kamel EG
J Egypt Soc Parasitol; 2005 Apr; 35(1):59-68. PubMed ID: 15880995
[TBL] [Abstract][Full Text] [Related]
20. Detection and differentiation of Entamoeba histolytica and Entamoeba dispar isolates in clinical samples by PCR.
Helmy MM; Rashed LA; Abdel-Fattah HS
J Egypt Soc Parasitol; 2007 Apr; 37(1):257-74. PubMed ID: 17580582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
